MedinCell Revenue

In the fiscal year ending March 31, 2026, MedinCell had annual revenue of 19.52M EUR, down -23.21%. MedinCell had revenue of 7.91M in the half year ending March 31, 2026, with 286.42% growth.

Revenue

19.52M

Revenue Growth

-23.21%

P/S Ratio

36.80

Revenue / Employee

172.18K

Employees

141

Market Cap

893.48M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	19.52M	-5.90M	-23.21%
Mar 31, 2025	25.42M	16.39M	181.43%
Mar 31, 2024	9.03M	-857.00K	-8.67%
Mar 31, 2023	9.89M	1.55M	18.60%
Mar 31, 2022	8.34M	152.00K	1.86%
Mar 31, 2021	8.19M	5.33M	187.03%
Mar 31, 2020	2.85M	1.41M	97.78%
Mar 31, 2019	1.44M	-5.00M	-77.61%
Mar 31, 2018	6.44M	-2.09M	-24.54%
Mar 31, 2017	8.53M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company Name	Revenue
Valneva SE	142.94M
Genfit	70.85M
Cellectis	55.86M
Nanobiotix	32.59M
Innate Pharma	9.01M
Transgene	7.21M
Inventiva	6.76M
Sensorion	5.81M

Revenue Rankings

MedinCell News

11 days ago - Medincell's Dr Grace Kim to Participate in Piper Sandler CNS Symposium - Business Wire
25 days ago - Medincell: UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook - Business Wire
26 days ago - Medincell Continues to Strengthen and Renew its Board of Directors with the Proposed Appointment of Dr. Elisabeth Svanberg - Business Wire
5 weeks ago - Medincell Aligns Debt Maturity with Its Expected Revenue Growth Trajectory - Business Wire
2 months ago - MedinCell Slides: Corporate presentation - Filings
2 months ago - MedinCell Transcript: H2 25/26 - Transcripts
2 months ago - MedinCell Earnings release: H2 2026 - Filings
2 months ago - MedinCell Slides: H2 2026 - Filings

More News